MIRA
INFORM REPORT
|
Report Date : |
17.03.2008 |
IDENTIFICATION
DETAILS
|
Name : |
ATTABAK
PHARMACEUTICALS |
|
|
|
|
Registered Office : |
5-C, Industrial Area I-10/3, Islamabad |
|
|
|
|
Country : |
Pakistan |
|
|
|
|
Date of Incorporation : |
1998 |
|
|
|
|
Legal Form : |
Sole Proprietorship |
|
|
|
|
Line of Business : |
Manufacture, Import and Marketing of
Veterinary Medicines and Pharmaceutical |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
Business Name
ATTABAK
PHARMACEUTICALS
Full Address
|
Registered
Address & Factory |
|
5-C, Industrial Area I-10/3, Islamabad, Pakistan |
|
Tel |
92 (51) 4434124, 4434125 |
|
Fax |
92 (51) 4432901 |
|
Email |
Short Description Of Business
|
Nature of Business |
Manufacture,
Import & Marketing of Veterinary Medicines & Pharmaceutical |
|
Year Established |
1998 |
|
National Tax # |
1005729 |
Branches
None
Legal Status
Subject Company was established as a Proprietorship business in 1998
Details of Proprietor
|
Names |
Nationality |
Address |
Occupation |
Designation |
|
Dr. Syed Israr Hussain Shah Dr. Moinuddin Khan |
Pakistani Pakistani |
5-C,
Industrial Area I-10/3, Islamabad 5-C,
Industrial Area I-10/3, Islamabad |
Business Business |
Proprietor Manager (Sales) |
Associates
A. Subsidiary
None
B. Associated Companies
- Do -
Business Activities
(1) Subject Company is engaged in manufacture, import & marketing of Veterinary Medicines & Pharmaceutical.
(2) It purchases raw material against D/A basis.
(3) Its mainly import from Austria, Germany & U.S.A.
(3) Its’ major
customers are Feed Millers, Whole Sale
Traders, Retail Traders,
Government Veterinary Organizations, Live Stocks and Farmers.
(4) Subject operates from caption leased factory premises of area measuring 2,000 Sq.Yard. which is situated in industrial area.
(5) Subject employs about 78 persons in its set up.
Products
Manufacture, Import & Marketing of
Veterinary Medicine & Pharmaceutical.
Annual Sales Volume
|
Year |
In Pak Rupees
|
|
2006 |
30,000,000/- (Estimated) |
Capacity & Production
The capacity and
production of the company’s plant is indeterminable as it is multi- product and
involves various processes of manufacture.
Authorized Distributors
Mainly in Islamabad & Lahore
Bankers
ABN AMRO Bank,
Pakistan.
Standard Chartered
Bank, Pakistan.
Bank Alfalah
Limited, Pakistan.
Foreign Exchange Rates
|
Currency |
Unit |
Pakistani Rupee |
|
US Dollar |
1 |
Rs. 62.90 |
|
UK Pound |
1 |
Rs.126.75 |
|
Euro |
1 |
Rs. 98.35 |
Comments
Subject Company was established in 1998 and
is engaged in manufacture, import
& marketing of Veterinary Medicines & Pharmaceutical. Trade relations are reported as fair. Subject can be
considered for normal business dealings at usual trade terms and conditions.
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)